Duke Study Finds Mitochondrial Transfer Between Cells Can Reduce Chronic Nerve Pain
Similar Articles
Researchers Restore Memory in Dementia Models by Fixing Mitochondrial Activity
Brain Circuit Discovery Could Offer New Path to Treat Chronic Pain
Engineered Nanoparticles Show Promise in Restoring Brain Waste Removal in Alzheimer's Mouse Model
NAD+ Supplements Show Promise in Early Studies but Face Absorption and Cost Hurdles
Researchers Identify Brain Cell Process That Removes Alzheimer's Plaques in Mice
Researchers at Duke University have identified a cellular process that can alleviate chronic nerve pain. By transferring healthy mitochondria from support cells to damaged neurons, they achieved significant pain reduction in models of diabetic and chemotherapy-related neuropathy. The findings point to a potential new therapeutic approach for conditions affecting millions.
Facts First
- Transferring healthy mitochondria to damaged nerve cells significantly reduced pain in models of diabetic neuropathy and chemotherapy-related nerve damage.
- Satellite glial cells pass mitochondria to sensory neurons through structures called tunneling nanotubes, a process that breaks down in chronic pain.
- Injecting healthy mitochondria directly into nerve clusters provided pain relief lasting up to 48 hours in mice.
- The protein MYO10 is critical for creating the tunneling nanotubes that allow mitochondrial transfer.
- The effectiveness depended on mitochondrial quality; mitochondria from donors with diabetes produced no benefit.
What Happened
Researchers at Duke University School of Medicine found that satellite glial cells pass healthy mitochondria directly into sensory neurons through structures called tunneling nanotubes. When this mitochondrial transfer process breaks down, nerve fibers can deteriorate, causing symptoms like pain, tingling, and numbness. In mice, increasing mitochondrial transfer resulted in a drop in pain-related behaviors by as much as 50%. The researchers tested a direct method by injecting isolated, healthy mitochondria into clusters of nerve cells, which significantly reduced pain linked to diabetic neuropathy and chemotherapy-related nerve damage.
Why this Matters to You
If you or someone you know lives with the debilitating effects of chronic nerve pain—where even light touch can feel unbearable—this research may offer a new avenue for hope. The study suggests a potential future treatment could work by repairing the cellular energy supply in damaged nerves, rather than just masking symptoms. This approach could be particularly relevant for the millions managing pain from conditions like diabetic neuropathy or side effects from chemotherapy.
What's Next
The researchers stated that more studies are required to understand precisely how nanotubes deliver mitochondria within living nerve tissue. Further research will be needed to translate these findings from animal models into safe and effective therapies for humans. The identification of the critical protein MYO10 may also open doors for developing drugs that can enhance or mimic this natural mitochondrial transfer process.